###begin article-title 0
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">S&#8414;</xref>
###xml 79 79 79 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2"/>
Cbl Enforces an SLP76-dependent Signaling Pathway for T Cell Differentiation*Sâƒž
###end article-title 0
###begin p 1
###xml 196 216 196 216 <email xmlns:xlink="http://www.w3.org/1999/xlink">chiangj@mail.nih.gov</email>
 To whom correspondence should be addressed: Bldg. 10, 4B36, Experimental Immunology Branch, NCI, National Institutes of Health, Bethesda, MD 20892. Tel.: 301-496-1376; Fax: 301-496-0887; E-mail: chiangj@mail.nih.gov. 
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 529 532 529 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slp76</italic>
###xml 1098 1101 1094 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1265 1268 1261 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y3F</italic>
###xml 1515 1518 1507 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1521 1524 1513 1516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
###xml 1245 1249 <span type="species:ncbi:10090">mice</span>
###xml 1284 1288 <span type="species:ncbi:10090">mice</span>
###xml 1379 1383 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
A signaling pathway involving ZAP-70, LAT, and SLP76 has been regarded as essential for receptor-driven T cell development and activation. Consistent with this model, mice deficient in SLP76 have a complete block at the double negative 3 stage of T cell development. Recently, however, it has been reported that inactivation of Cbl, a ubiquitin-protein isopeptide ligase, partially rescues T cell development in SLP76-deficient mice. To probe the influence of Cbl on domain-specific SLP76 functions, we reconstituted SLP76-/- Cbl-/- mice with Slp76 transgenes bearing mutations in each of three functional domains of SLP76 as follows: Y3F, in which the amino-terminal tyrosine residues of SLP76 were mutated, eliminating sites of SLP76 interaction with Vav, Nck, and Itk; Delta20, in which 20 amino acids in the proline-rich region of SLP76 were deleted, removing a binding site for Gads; and RK, in which arginine 448 of SLP76 was replaced by lysine, abolishing function of the Src homology 2 domain. Although each of these transgenes has been shown to partially rescue T cell development in SLP76-/- mice, we report here that Cbl inactivation completely reverses the severe double negative 3 developmental block that occurs in SLP76-deficient mice expressing the Y3F transgene (Y3F mice) and partially rescues the defect in positive selection in T cell receptor transgenic Y3F mice, but in contrast fails to rescue thymic development of SLP76-deficient mice expressing the Delta20 or RK transgene. Rescue in SLP76-/-Cbl-/-Y3F double-positive thymocytes is associated with enhanced tyrosine phosphorylation of signaling molecules, including Lck, Vav, PLC-gamma1, and ERKs, but not Itk, in response to T cell receptor stimulation. Thus, our data demonstrate that Cbl suppresses activation of a bypass signaling pathway and thereby enforces SLP76 dependence of early T cell development.
###end p 4
###begin p 5
###xml 51 80 51 80 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 263 276 263 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by a National Institutes of Health grant (NCI Intramural Research Program). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 5
###begin p 6
The on-line version of this article (available at ) contains supplemental Fig. 1.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">2</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 594 595 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 645 646 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 649 650 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 808 809 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 812 813 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 820 821 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 824 825 810 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1086 1087 1072 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 1089 1090 1075 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 1092 1093 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
T cell development proceeds through multiple stages that regulate the generation and selection of T cells whose T cell receptors (TCR)2 have an appropriate range of affinity for peptides presented by major histocompatibility complex (MHC) molecules (1). Precursors give rise to immature CD4-CD8- double negative (DN) cells that can be further divided into DN1, DN2, DN3, and DN4 stages, distinguished by cell surface phenotype as well as by critical events, including expansion of DN3 cells that have successfully rearranged TCRbeta and have expressed and signaled through the pre-TCR complex (2). DN3 cells differentiate to the DN4 and then CD4+CD8+ double-positive (DP) stage following pre-TCR signaling. DP thymocytes rearrange TCRalpha, express a mature TCRalphabeta receptor, and develop into mature CD4+CD8- or CD4-CD8+ single-positive (SP) cells through a process of positive and negative selection that is based on signaling through this mature TCR and selection of a T cell repertoire that is tolerant to self but capable of responding to foreign-peptide-MHC (pMHC) complexes (1, 3, 4). Finally, SP cells exit from the thymus as mature T cells capable of recognizing and responding to foreign antigens.
###end p 8
###begin p 9
###xml 376 377 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 489 490 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 491 492 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 579 582 576 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 591 594 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 661 662 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 664 665 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 673 676 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 748 751 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 808 809 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
The signals from pre-TCR and TCR, which determine the fate of developing thymocytes, have been intensely studied. Ligation of the TCR by pMHC complexes results in activation of a signaling cascade initiated by phosphorylation and activation of TCR-zeta, Lck, and ZAP-70, which in turn phosphorylate downstream targets, including LAT and SLP76. ZAP-70, LAT and SLP76 proteins (3) have been shown to be essential for thymocyte development by studies, including genetic manipulation in mice (5-8). There are essentially no detectable DP or SP thymocytes or peripheral T cells in LAT-/- or SLP76-/- mice, in which thymocyte development is blocked at the DN3 stage (5, 7). ZAP70-/- thymocytes are blocked at the DP stage of T cell development, and ZAP70-/- mice have very few SP thymocytes or peripheral T cells (6). These studies suggest that signal transduction required for early T cell development proceeds through a pathway that involves critical roles of multiple molecules, including ZAP-70, LAT, and SLP76.
###end p 9
###begin p 10
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 1022 1023 1022 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 1025 1026 1025 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1506 1508 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1510 1512 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
###xml 1610 1614 <span type="species:ncbi:10090">mice</span>
###xml 1861 1865 <span type="species:ncbi:10090">mice</span>
SLP76 consists of three functional domains as follows: an amino-terminal domain containing targets for tyrosine phosphorylation, a proline-rich region, and a carboxyl-terminal SH2 domain (9). The amino-terminal tyrosine residues (Tyr-112, Tyr-128, and Tyr-145) are phosphorylated by tyrosine kinases following TCR engagement, enabling SLP76 to interact with Vav, a Rho guanine nucleotide exchange factor, Nck, an adaptor protein, and Itk, a member of Tec family PTK. The proline-rich region of SLP76 has the capacity to bind Gads, a Grb2 homolog, which results in the recruitment of SLP76 to cell surface membrane lipid rafts through binding to LAT following TCR engagement. The carboxyl-terminal SH2 domain of SLP76 interacts with ADAP (adhesion and degranulation-promoting protein) (10) an adaptor protein, and HPK-1, a serine kinase (9). Reconstitution of SLP76-deficient mice with transgenes containing mutations in each of these domains has demonstrated that each region is required for normal thymocyte development (5, 8). Two groups have reconstituted SLP76-deficient mice with T cell-specific expression of wild-type and mutant SLP76 transgenes, including a mutant in which three tyrosine residues (Tyr-112, Tyr-128, and Tyr-145) in the amino-terminal domain of SLP76 were substituted by phenylalanines (Y3F); a mutant in which 20 amino acids (amino acids 224-244) in the proline-rich region of SLP76 were deleted (Delta20); and a mutant in which arginine 448 of SLP76 was replaced by lysine (RK) (11, 12). The profound defects in T cell development and activation that are observed in SLP76 knock-out mice are completely reversed by reconstitution with a wild-type SLP76 transgene. In contrast, however, reconstitution with SLP76 that has been mutated in any of its three functional domains only partially rescues T cell development in SLP76 knock-out mice.
###end p 10
###begin p 11
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 395 398 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 558 564 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 2000 2005 1996 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slp76</italic>
###xml 2181 2184 2173 2176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2570 2572 2558 2560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 399 404 <span type="species:ncbi:10090">mouse</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
###xml 1769 1773 <span type="species:ncbi:10090">mice</span>
###xml 1976 1980 <span type="species:ncbi:10090">mice</span>
c-Cbl (Cbl) is a ubiquitin ligase and adaptor protein (regulator) with multiple domains that associate with multiple molecules involved in signal transduction (13). Thymocytes from Cbl knock-out mice have enhanced cell surface expression of TCR and CD3 in comparison with control mice (14, 15). In addition, it has been observed that phosphorylation of ZAP-70, LAT, and SLP76 is increased in Cbl-/- mouse thymocytes (14, 15). Recently, we reported that inactivation of Cbl partially rescues T cell development in LAT and SLP76-deficient mice (16), and Myers et al. (17) reported that inactivation of Cbl partially rescues T cell development in ZAP-70-deficient mice. These observations indicate that Cbl mediates requirements for LAT, SLP76, and ZAP-70 by preventing signaling that is capable of supporting T cell differentiation independent of LAT, SLP76, or ZAP-70. However, the rescue of T cell development in these model systems is strikingly incomplete, failing to substantially reconstitute development through the pre-TCR-dependent DN3-DN4 transition and thus failing to generate normal numbers of DP or functionally mature SP thymocytes. These findings suggest that Cbl inactivation functions to enable pathways that are capable of bypassing some but not all of the requirements for ZAP-70, LAT, and SLP76 during T cell development. To define these signaling pathways, normally suppressed by Cbl, that can support T cell development, we assessed the ability of Cbl inactivation to rescue T cell development in the presence of Y3F, Delta20, or RK SLP76 mutant transgenes. In this study, we report that Cbl inactivation completely reverses the DN3-DN4 developmental defect and partially reverses alterations in positive selection in thymocytes of SLP76 knock-out mice reconstituted with the SLP76 mutant Y3F, which lacks amino-terminal phosphotyrosine residues. In contrast, Cbl inactivation has no effect on the thymic developmental defects observed in SLP76 knock-out mice reconstituted with Slp76 transgenes mutated in the proline-rich Gads-binding region (Delta20) or the carboxyl-terminal SH2 domain (RK). Biochemical studies revealed that rescue of development in SLP76-/-Y3F thymocytes by inactivation of Cbl was marked by reversal of defects in tyrosine phosphorylation of multiple molecules, including Lck, Vav, PLC-gamma1, and ERKs in response to TCR stimulation of DP thymocytes. Thus, Cbl normally enforces SLP76 dependence of T cell development by inhibiting an alternative pathway that may be independent of SLP76 association with Vav, Nck, and Itk (18).
###end p 11
###begin title 12
MATERIALS AND METHODS
###end title 12
###begin p 13
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mice</italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 31 33 31 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 117 119 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 173 175 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 193 196 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 203 206 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 255 256 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 156 171 <span type="species:ncbi:10090">transgenic mice</span>
###xml 216 231 <span type="species:ncbi:10090">transgenic mice</span>
Mice-c-Cbl knock-out (Cbl-/-) (14), SLP76 knock-out (SLP76-/-) (5), and SLP76 transgenic (Y3F, Delta20 and RK) mice (12) were described previously. AND TCR transgenic mice (19) were bred to Cbl-/-, SLP76-/-, and Y3F transgenic mice on a B6 background (H-2b). All animals were housed at BIOQUAL, Inc. (Rockville, MD).
###end p 13
###begin p 14
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibodies</italic>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 658 664 <span type="species:ncbi:9986">rabbit</span>
Antibodies-Anti-mouse CD3epsilon (2C11), anti-CD28 (4F10), anti-ZAP-70, anti-TCR-zeta, anti-CD4-PE, anti-CD8-FITC, anti-TCR-Vbeta3-biotin, anti-TCR-Valpha11-biotin, anti-CD25-biotin, anti-leu4-biotin, anti-CD62L-biotin, anti-CD5-biotin, anti-CD69-biotin, anti-HSA-biotin, and anti-TCR-beta (H57)-biotin monoclonal antibodies were purchased from Pharmingen. Anti-phosphotyrosine (4G10), anti-PLC-gamma1, and anti-Itk monoclonal antibodies were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Anti-ERKs, anti-pY(416)Lck, anti-Lck, and anti-phospho-ERKs polyclonal antibodies were purchased from Cell Signaling (Beverly, MA). Anti-Vav1 polyclonal rabbit antibody was purchased from Santa Cruz Biotechnology (San Diego, CA).
###end p 14
###begin p 15
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blot Analysis</italic>
###xml 230 231 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 253 254 249 250 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 264 265 260 261 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 268 269 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 271 272 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Western Blot Analysis-Thymocytes were incubated with 5 mug/ml biotin-conjugated anti-CD3 for 30 min and then stimulated with 20 mug/ml streptavidin for the indicated time. The stimulated cells were lysed in buffer containing 50 mum Tris (pH 7.4), 150 mum NaCl, 1 mm Na2VO4, 1% Nonidet P-40, and protease inhibitor mixture. Protein lysates were used for biochemical analysis.
###end p 15
###begin title 16
RESULTS
###end title 16
###begin p 17
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 612 615 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 618 621 614 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 631 634 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 637 640 633 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 658 661 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 664 667 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
To assess the function of Cbl in regulating T cell differentiation, we determined the effect of Cbl inactivation in mice expressing SLP76 mutants, each of which is associated with defective T cell development. SLP76-/-Cbl-/- mice were bred with each of three mutant SLP76 transgenic strains (12) as follows: Y3F, in which three tyrosine residues in the amino-terminal domain of SLP76 were replaced by phenylalanines; Delta20, in which 20 amino acids in the proline-rich region of SLP76 were deleted; and RK, in which arginine 448 of SLP76 was replaced by lysine. The resulting mouse strains were designated SLP76-/-Cbl-/-Y3F, SLP76-/-Cbl-/-Delta20, and SLP76-/-Cbl-/-RK.
###end p 17
###begin p 18
###xml 0 82 0 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbl Inactivation Fails to Rescue the Defects in Thymic T Cell Development in SLP76</italic>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 90 102 86 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">20 and SLP76</italic>
###xml 102 103 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 103 104 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 103 104 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 104 105 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 105 112 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RK Mice</italic>
###xml 170 173 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 267 270 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 277 278 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 280 282 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 350 353 342 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 366 367 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 360 367 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 370 371 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 387 388 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 392 393 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 418 421 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 457 460 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 554 555 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 548 555 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 611 614 599 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 664 665 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 658 665 642 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 108 112 <span type="species:ncbi:10090">Mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
Cbl Inactivation Fails to Rescue the Defects in Thymic T Cell Development in SLP76-/-Delta20 and SLP76-/-RK Mice-Consistent with previous reports, reconstitution of SLP76-/- mice with the Delta20 transgene partially rescues the thymocyte developmental defect of SLP76-/- mice (5, 12). In contrast to the absence of detectable DP and SP cells in SLP76-/- mice (Fig. 1A) (5), the DN3 (CD25+CD44-) block observed in SLP76-/- mice is partially relieved in SLP76-/-Delta20 mice, and DP and SP thymocytes are generated in the presence of this transgene (Fig. 1B). However, the total cellularity of thymocytes in SLP76-/-Delta20 mice is only 20% that of wild type (Fig. 1B).
###end p 18
###begin p 19
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 130 133 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 150 153 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 156 159 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 288 291 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 321 324 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 327 330 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 381 382 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 386 387 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 418 421 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 468 469 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 462 469 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 623 626 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
Inactivation of Cbl had no significant effect on the defects in thymocyte development observed in SLP76-/-Delta20 mice. Both SLP76-/-Delta20 and SLP76-/-Cbl-/-Delta20 mice had much reduced total thymic cellularity, as well as reduced proportions of SP cells compared with wild-type or Cbl-/- mice. DN development in SLP76-/-Cbl-/-Delta20 mice was partially blocked at the DN3 (CD25+CD44-) stage, again similar to SLP76-/-Delta20 mice with intact Cbl expression (Fig. 1B). These data indicate that Cbl inactivation does not overcome or bypass the requirement for the proline-rich Gads-binding domain that is mutated in SLP76-/-Delta20 mice.
###end p 19
###begin p 20
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 221 228 221 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 320 323 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
In SLP76-/- mice carrying the SLP76 RK transgene, overall thymic cellularity is near-normal, as are proportions of DP and SP cells; however, the DN development of thymocytes is still partially blocked in SLP76-/-RK mice (Fig. 1C) (12). Again, Cbl inactivation failed to alter the phenotype of SLP76-/-RK mice, with SLP76-/-RK and SLP76-/-Cbl-/-RK thymuses having similarly decreased CD4/CD8 ratios and partial blocks in DN3 to DN4 transition (Fig. 1C).
###end p 20
###begin p 21
###xml 0 70 0 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbl Inactivation Rescues Defects in Thymic T Cell Development in SLP76</italic>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y3F Mice</italic>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 700 703 700 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y3F</italic>
###xml 770 773 770 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 786 789 786 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 912 915 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 930 931 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 936 937 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 922 937 922 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic> and <italic>B</italic></xref>
###xml 1068 1071 1068 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1116 1117 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1110 1117 1110 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1147 1150 1147 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1192 1193 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1197 1198 1197 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1212 1213 1212 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1217 1218 1217 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1259 1262 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1275 1276 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1269 1276 1269 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1297 1300 1297 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1303 1306 1303 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1388 1389 1388 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1473 1474 1473 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1479 1480 1479 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1465 1480 1465 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic> and <italic>C</italic></xref>
###xml 1562 1565 1562 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 77 81 <span type="species:ncbi:10090">Mice</span>
###xml 774 779 <span type="species:ncbi:10090">mouse</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
###xml 1104 1108 <span type="species:ncbi:10090">mice</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
###xml 1310 1314 <span type="species:ncbi:10090">mice</span>
###xml 1569 1573 <span type="species:ncbi:10090">mice</span>
Cbl Inactivation Rescues Defects in Thymic T Cell Development in SLP76-/-Y3F Mice-The amino-terminal tyrosine residues of SLP76 are phosphorylated by tyrosine kinases following TCR engagement, which enables SLP76 to interact with Vav, a Rho guanine nucleotide exchange factor, Nck, an adaptor protein, and Itk, a member of Tec family protein-tyrosine kinase, each through association with a distinct phosphotyrosine on SLP76 (9). The SLP76 mutant Y3F, in which three tyrosine residues (Tyr-112, Tyr-128, and Tyr-145) in the amino-terminal domain of SLP76 were substituted by phenylalanines, is thus unable to interact with Vav, Nck, and Itk (9). Consistent with previously reported results (12), the Y3F transgene only partially rescued thymocyte development of an SLP76-/- mouse. SLP76-/-Y3F transgenics had significantly decreased total thymic cellularity and numbers of DP cells compared with wild-type or Cbl-/- mice (Fig. 2, A and B). The percentage of CD4 cells was decreased relative to controls, whereas the percentage of DN was dramatically increased in SLP76-/-Y3F thymus compared with control mice (Fig. 2A). The DN development of SLP76-/-Y3F was severely impaired at the DN3 (CD25+CD44-) to DN4 (CD25-CD44-) transition relative to wild-type or Cbl-/- mice (Fig. 2A). In contrast, SLP76-/-Cbl-/-Y3F mice had normal thymic cellularity, with normal proportions and numbers of CD4+ SP and DP cells, as well as normalized proportions of DN3 and DN4 subsets (Fig. 2, A and C). Thus, Cbl inactivation completely rescues the defect of DN development in SLP76-/-Y3F mice.
###end p 21
###begin p 22
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 316 319 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 382 383 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 376 383 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 435 438 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 441 444 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 492 495 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 572 575 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 676 679 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 686 689 677 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 703 706 694 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 709 712 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 728 731 719 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 885 886 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 879 886 867 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 914 917 902 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1183 1186 1168 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1193 1196 1178 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1210 1213 1195 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1216 1219 1201 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
The effect of Cbl inactivation on thymic development was further analyzed by characterizing the phenotype of cells that develop through this pathway. TCR expression was up-regulated in DP thymocytes of Cbl-/- mice relative to wild-type controls, as described previously (12). Cell surface TCRbeta expression on SLP76-/-Y3F DP cells was similarly elevated by Cbl inactivation (Fig. 2D). Levels of cell surface TCRbeta expressed on SLP76-/-Cbl-/-Y3F DP thymocytes are equivalent to those on Cbl-/- DP cells, and significantly increased in comparison with wild-type and SLP76-/-Y3F mice. In contrast, TCRbeta expression on CD4 single-positive cells was similar for wild-type, Cbl-/-, SLP76-/-Y3F, and SLP76-/-Cbl-/- Y3F mice. SLP76-/-Y3F had dramatically decreased expression of TCRbeta on CD8 single-positive cells, and this decrease was completely normalized by Cbl inactivation (Fig. 2D). It is possible that SLP76-/-Y3F CD8 cells expressing low density of TCR represent, at least in part, an increased population of immature SP cells and that this population is substantially reduced by Cbl inactivation. Patterns of CD3 expression were similar to those of TCRbeta on wild-type, Cbl-/-, SLP76-/-Y3F, and SLP76-/-Cbl-/-Y3F thymocytes (data not shown).
###end p 22
###begin p 23
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 824 827 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 931 932 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 925 932 925 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 998 1001 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1004 1007 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1072 1073 1072 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1066 1073 1066 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
The level of HSA expression has been shown to be a marker for the maturational state of SP thymocytes, with less mature cells expressing higher levels of HSA, and levels decreasing progressively with maturation (20). SLP76-/-Y3F DP and CD8+ thymocytes had increased expression of HSA, whereas SLP76-/-Cbl-/-Y3F DP and CD8+ thymocytes had normal expression of HSA, indicating that they had progressed to a more mature state (Fig. 2D). CD5 is a negative regulator of signal transduction, and its level of cell surface expression has been shown to be proportional to the strength of TCR signaling of DP thymocytes. CD69 is an early marker of TCR signaling and in DP thymocytes is an indication that cells have been positively selected by recognition of a selecting ligand. Expression of both CD5 and CD69 was decreased on SLP76-/-Y3F DP thymocytes, indicating that these cells had received diminished signaling through the TCR (Fig. 2D). Notably, expression of both CD5 and CD69 was increased in SLP76-/-Cbl-/-Y3F DP cells to levels comparable with wild-type DP cells (Fig. 2D).
###end p 23
###begin p 24
###xml 0 76 0 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Expression of a TCR Transgene Rescues Defective DN3-DN4 Development in SLP76</italic>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y3F Mice</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 528 531 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 545 548 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 565 567 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 591 594 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 622 625 612 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 772 773 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 791 793 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 851 852 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 865 866 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 859 866 849 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 925 928 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 955 956 943 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 993 996 981 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1019 1020 1005 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1083 1086 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1123 1126 1109 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1165 1166 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1159 1166 1145 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1177 1178 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1171 1178 1157 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1284 1287 1270 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1303 1304 1289 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1297 1304 1283 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1329 1332 1315 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1353 1354 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1347 1354 1333 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 83 87 <span type="species:ncbi:10090">Mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
###xml 1094 1098 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
###xml 1341 1345 <span type="species:ncbi:10090">mice</span>
Expression of a TCR Transgene Rescues Defective DN3-DN4 Development in SLP76-/-Y3F Mice-As shown above, thymic development in SLP76-/-Y3F mice is marked by a defect in maturation at the DN3-DN4 transition or beta checkpoint, a transition that is mediated by signaling through the pre-TCR. It has been observed that expression of a transgenic alphabeta TCR can replace the pre-TCR in mediating DN3-DN4 differentiation. To first determine whether DN3-DN4 differentiation mediated by a transgenic TCR is also defective in the SLP76-/-Y3F mice, the AND transgenic TCR (19) was expressed in SLP76-/-Y3F mice. Expression of the AND transgene in wild-type mice results in positive selection that is highly skewed toward development of CD4 SP cells, as reported previously for I-Ek-expressing mice (19), and is shown here to also be the case for wild-type H-2b mice (Fig. 3A). Notably, total thymocyte numbers were increased in SLP76-/-Y3F.AND mice (78 +/- 8 x 106 for 3 mice) in comparison with SLP76-/-Y3F mice (21 +/- 7 x 106 for 5 mice), whereas the percentage of DN was reduced in SLP76-/-Y3F.AND mice in comparison with SLP76-/-Y3F mice (representative data in Fig. 2A and Fig. 3A). Analysis of DN development showed that the defect in DN3-DN4 transition observed in thymocytes of SLP76-/-Y3F mice (Fig. 2B) was normalized in SLP76-/- Y3F.AND mice (Fig. 3B). Thus, mutation of amino-terminal tyrosines in the Y3F mutant results in deficient DN3-DN4 transition mediated by the pre-TCR, but it does not compromise development mediated by a transgenic mature alphabeta TCR.
###end p 24
###begin p 25
###xml 0 80 0 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbl Inactivation Modulates Positive Selection of TCR Transgenic T Cells in SLP76</italic>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y3F Mice</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 283 284 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 286 288 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 318 321 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 403 406 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 506 509 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 572 575 565 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 695 698 688 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 718 719 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 712 719 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 833 834 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 827 834 816 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 884 887 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 890 893 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 906 909 892 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 913 916 899 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1064 1067 1043 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1070 1073 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1192 1193 1165 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1381 1382 1346 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1375 1382 1340 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1390 1393 1355 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1397 1400 1362 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1521 1524 1486 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1567 1570 1532 1535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1573 1576 1538 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1677 1678 1640 1641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1680 1681 1643 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1686 1692 1649 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 1709 1710 1670 1671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1712 1713 1673 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1726 1727 1687 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1720 1727 1681 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1793 1794 1748 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1799 1805 1754 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 1818 1819 1771 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1832 1833 1785 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1826 1833 1779 1786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1864 1867 1817 1820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1936 1939 1889 1892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1942 1945 1895 1898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1968 1969 1919 1920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 2013 2014 1960 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2019 2020 1966 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2005 2020 1952 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A</italic> and <italic>C</italic></xref>
###xml 2203 2204 2136 2137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2197 2204 2130 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 2440 2441 2361 2362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2434 2441 2355 2362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 2578 2581 2499 2502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 2600 2603 2521 2524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 87 91 <span type="species:ncbi:10090">Mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
###xml 1408 1412 <span type="species:ncbi:10090">mice</span>
###xml 1533 1537 <span type="species:ncbi:10090">mice</span>
###xml 1585 1589 <span type="species:ncbi:10090">mice</span>
###xml 1875 1879 <span type="species:ncbi:10090">mice</span>
###xml 1949 1953 <span type="species:ncbi:10090">mice</span>
###xml 2607 2611 <span type="species:ncbi:10090">mice</span>
Cbl Inactivation Modulates Positive Selection of TCR Transgenic T Cells in SLP76-/-Y3F Mice-Expression of TCR transgenes has been a valuable approach to assessing T cell repertoire selection. The AND transgene is composed of Valpha11 and Vbeta3 chains and is specific for cytochrome c (19). Although expression of the AND transgene substantially reversed the DN3-DN4 block in thymic development in SLP76-/-Y3F mice, as reflected in increased numbers of DP and SP cells, the repertoire selected in the SLP76-/-Y3F.AND mice differed substantially from that selected in SLP76+/-.AND mice. Both CD4 and CD8 SP thymocytes were generated, but there was not a strong preponderance of CD4 cells in SLP76-/-Y3F.AND mice (Fig. 3A). When TCR expression was analyzed, CD4 SP thymocytes expressed homogeneously high levels of TCR Valpha11 (Fig. 3C) as well as Vbeta3 (data not shown) in both SLP76+/-Cbl+/-AND and SLP76+/- Cbl-/-AND mice, indicating that selection was highly efficient for cells expressing transgenic alpha and beta chains. However, the TCR repertoire in SLP76-/-Cbl+/-Y3F.AND thymuses was markedly different. Valpha11 expression in these mice was bimodal, with the majority (84 +/- 14%, n = 3) of thymocytes expressing low levels of Valpha11 and a smaller population expressing high levels of Valpha11 comparable with those expressed in SLP76 wild-type AND transgenics (Fig. 3C). SLP76-/- Cbl-/-Y3F.AND mice were analyzed to determine whether Cbl inactivation would affect the altered TCR selection observed in SLP76-/- Y3F.AND mice. Inactivation of Cbl in SLP76-/-Cbl-/- Y3F.AND mice resulted in a substantial increase in the total number of CD4 SP cells (21 +/- 6.8 x 106, n = 3 versus 5.3 +/- 2.3 x 106, n = 3) (Fig. 3A) and in the percentage of Valpha11-high CD4 SP cells (53 +/- 9%, n = 3 versus 17 +/- 10%, n = 3) (Fig. 3C) over levels observed in SLP76-/-Y3F.AND mice, although these values did not reach the levels in SLP76+/-Cbl+/-AND mice (65 +/- 7 x 106 CD4 SP cells, 100% Valpha11-high) (Fig. 3, A and C). This difference in Valpha11 expression resulting from Cbl inactivation was not the result of differences in overall expression of TCRalphabeta as measured by Cbeta staining (Fig. 3C), and thus reflects a shift from selection of cells expressing low levels of transgenic Valpha11 and high levels of endogenous nontransgenic Valpha to predominant selection of cells expressing Valpha11-high transgenic receptors (Fig. 3C). Thus, inactivation of Cbl both enhanced overall CD4 SP selection and altered specific TCR repertoire selection in the presence of the AND transgene in SLP76-/-Y3F mice.
###end p 25
###begin p 26
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 104 107 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 9 115 9 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cbl inactivation fails to rescue the defects of T cell development in SLP76<sup>-/-</sup>&#916;20 and SLP76<sup>-/-</sup>RK mice.</bold>
###xml 115 117 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 139 142 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 145 148 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 170 173 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 176 179 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 186 189 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 251 258 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 325 326 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 330 331 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 337 338 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 344 345 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 349 350 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 355 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 360 361 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 374 384 370 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 462 467 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 479 486 475 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 533 534 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 537 538 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 548 549 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 552 553 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 563 564 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 567 568 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 578 579 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 582 583 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 595 596 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 600 601 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 613 614 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 618 619 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 631 632 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 636 637 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 653 654 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 658 659 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 673 675 669 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 697 700 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 703 706 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 708 717 704 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wild-type</italic>
###xml 725 728 721 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 731 734 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 739 742 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 750 753 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 756 759 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 773 776 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 794 797 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 800 803 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 847 854 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 898 899 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 903 904 887 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 910 911 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 917 918 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 922 923 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 927 928 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 933 934 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 947 957 931 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 1059 1066 1043 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 1113 1114 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1117 1118 1101 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1128 1129 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1132 1133 1116 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1144 1145 1128 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1148 1149 1132 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1160 1161 1144 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1164 1165 1148 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1177 1178 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1182 1183 1166 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1195 1196 1179 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1200 1201 1184 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1213 1214 1197 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1218 1219 1202 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1235 1236 1219 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1240 1241 1224 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1322 1324 1306 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 1346 1349 1330 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1352 1355 1336 1339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1374 1377 1358 1361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1380 1383 1364 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1388 1391 1372 1375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1399 1402 1383 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1405 1408 1389 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1417 1420 1401 1404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1434 1437 1418 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1441 1444 1425 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1483 1490 1467 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 1527 1528 1511 1512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1532 1533 1516 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1539 1540 1523 1524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1546 1547 1530 1531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1551 1552 1535 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1556 1557 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1562 1563 1546 1547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1576 1586 1560 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 1675 1680 1659 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 1746 1747 1730 1731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1750 1751 1734 1735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1761 1762 1745 1746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1765 1766 1749 1750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1777 1778 1761 1762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1781 1782 1765 1766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1793 1794 1777 1778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1797 1798 1781 1782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1810 1811 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1815 1816 1799 1800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1828 1829 1812 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1833 1834 1817 1818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1846 1847 1830 1831 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1851 1852 1835 1836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1868 1869 1852 1853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1873 1874 1857 1858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 9 1962 9 1946 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><bold>Cbl inactivation fails to rescue the defects of T cell development in SLP76<sup>-/-</sup>&#916;20 and SLP76<sup>-/-</sup>RK mice.</bold><italic>A,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type) and SLP76<sup>-/-</sup>Cbl<sup>+/-</sup> (SLP76<sup>-/-</sup>) mice were stained with antibodies specific for CD4 and CD8 (<italic>top row</italic>) or with antibodies specific for CD25 and CD44 after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice and total numbers of thymocytes for each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4(CD4<sup>+</sup>CD8<sup>-</sup>), CD8(CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. <italic>B,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (<italic>wild-type</italic>), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>&#916;20 (SLP76<sup>-/-</sup>&#916;20) and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>&#916;20 mice were stained with CD4 and CD8 (<italic>top row</italic>); or with CD25 and CD44 after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of three independent experiments. <italic>C,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>RK (SLP76<sup>-/-</sup>RK), and SLP76<sup>-/-</sup> Cbl<sup>-/-</sup>RK mice were stained with CD4 and CD8 (<italic>top row</italic>) or with CD25 and CD44 excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. Numbers in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of three or more independent experiments.</p>
###xml 9 1962 9 1946 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27"><bold>Cbl inactivation fails to rescue the defects of T cell development in SLP76<sup>-/-</sup>&#916;20 and SLP76<sup>-/-</sup>RK mice.</bold><italic>A,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type) and SLP76<sup>-/-</sup>Cbl<sup>+/-</sup> (SLP76<sup>-/-</sup>) mice were stained with antibodies specific for CD4 and CD8 (<italic>top row</italic>) or with antibodies specific for CD25 and CD44 after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice and total numbers of thymocytes for each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4(CD4<sup>+</sup>CD8<sup>-</sup>), CD8(CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. <italic>B,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (<italic>wild-type</italic>), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>&#916;20 (SLP76<sup>-/-</sup>&#916;20) and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>&#916;20 mice were stained with CD4 and CD8 (<italic>top row</italic>); or with CD25 and CD44 after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of three independent experiments. <italic>C,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>RK (SLP76<sup>-/-</sup>RK), and SLP76<sup>-/-</sup> Cbl<sup>-/-</sup>RK mice were stained with CD4 and CD8 (<italic>top row</italic>) or with CD25 and CD44 excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. Numbers in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of three or more independent experiments.</p></caption>
###xml 1962 1962 1946 1946 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0100966560001"/>
###xml 0 1962 0 1946 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="27"><bold>Cbl inactivation fails to rescue the defects of T cell development in SLP76<sup>-/-</sup>&#916;20 and SLP76<sup>-/-</sup>RK mice.</bold><italic>A,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type) and SLP76<sup>-/-</sup>Cbl<sup>+/-</sup> (SLP76<sup>-/-</sup>) mice were stained with antibodies specific for CD4 and CD8 (<italic>top row</italic>) or with antibodies specific for CD25 and CD44 after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice and total numbers of thymocytes for each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4(CD4<sup>+</sup>CD8<sup>-</sup>), CD8(CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. <italic>B,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (<italic>wild-type</italic>), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>&#916;20 (SLP76<sup>-/-</sup>&#916;20) and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>&#916;20 mice were stained with CD4 and CD8 (<italic>top row</italic>); or with CD25 and CD44 after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of three independent experiments. <italic>C,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>RK (SLP76<sup>-/-</sup>RK), and SLP76<sup>-/-</sup> Cbl<sup>-/-</sup>RK mice were stained with CD4 and CD8 (<italic>top row</italic>) or with CD25 and CD44 excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. Numbers in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of three or more independent experiments.</p></caption><graphic xlink:href="zbc0100966560001"/></fig>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
###xml 1030 1035 <span type="species:ncbi:10090">mouse</span>
###xml 1447 1451 <span type="species:ncbi:10090">mice</span>
###xml 1602 1606 <span type="species:ncbi:10090">mice</span>
###xml 1659 1664 <span type="species:ncbi:10090">mouse</span>
FIGURE 1.Cbl inactivation fails to rescue the defects of T cell development in SLP76-/-Delta20 and SLP76-/-RK mice.A, thymocytes from SLP76+/-Cbl+/- (wild type) and SLP76-/-Cbl+/- (SLP76-/-) mice were stained with antibodies specific for CD4 and CD8 (top row) or with antibodies specific for CD25 and CD44 after excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice and total numbers of thymocytes for each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4(CD4+CD8-), CD8(CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. B, thymocytes from SLP76+/-Cbl+/- (wild-type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-Delta20 (SLP76-/-Delta20) and SLP76-/-Cbl-/-Delta20 mice were stained with CD4 and CD8 (top row); or with CD25 and CD44 after excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. Results shown are representative of three independent experiments. C, thymocytes from SLP76+/-Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-RK (SLP76-/-RK), and SLP76-/- Cbl-/-RK mice were stained with CD4 and CD8 (top row) or with CD25 and CD44 excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. Results shown are representative of three or more independent experiments.
###end p 26
###begin p 27
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 95 98 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 0 106 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cbl inactivation fails to rescue the defects of T cell development in SLP76<sup>-/-</sup>&#916;20 and SLP76<sup>-/-</sup>RK mice.</bold>
###xml 106 108 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 130 133 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 136 139 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 161 164 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 167 170 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 177 180 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 242 249 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 316 317 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 321 322 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 328 329 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 335 336 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 340 341 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 345 346 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 351 352 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 365 375 361 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 453 458 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 470 477 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 524 525 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 528 529 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 539 540 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 543 544 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 554 555 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 558 559 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 569 570 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 573 574 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 586 587 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 591 592 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 604 605 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 609 610 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 622 623 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 627 628 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 644 645 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 649 650 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 664 666 660 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 688 691 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 694 697 690 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 699 708 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wild-type</italic>
###xml 716 719 712 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 722 725 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 730 733 726 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 741 744 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 747 750 743 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 764 767 756 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 785 788 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 791 794 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 838 845 822 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 889 890 873 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 894 895 878 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 901 902 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 908 909 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 913 914 897 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 918 919 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 924 925 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 938 948 922 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 1050 1057 1034 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 1104 1105 1088 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1108 1109 1092 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1119 1120 1103 1104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1123 1124 1107 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1135 1136 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1139 1140 1123 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1151 1152 1135 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1155 1156 1139 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1168 1169 1152 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1173 1174 1157 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1186 1187 1170 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1191 1192 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1204 1205 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1209 1210 1193 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1226 1227 1210 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1231 1232 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1313 1315 1297 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 1337 1340 1321 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1343 1346 1327 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1365 1368 1349 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1371 1374 1355 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1379 1382 1363 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1390 1393 1374 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1396 1399 1380 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1408 1411 1392 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1425 1428 1409 1412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1432 1435 1416 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1474 1481 1458 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 1518 1519 1502 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1523 1524 1507 1508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1530 1531 1514 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1537 1538 1521 1522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1542 1543 1526 1527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1547 1548 1531 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1553 1554 1537 1538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1567 1577 1551 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 1666 1671 1650 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 1737 1738 1721 1722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1741 1742 1725 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1752 1753 1736 1737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1756 1757 1740 1741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1768 1769 1752 1753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1772 1773 1756 1757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1784 1785 1768 1769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1788 1789 1772 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1801 1802 1785 1786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1806 1807 1790 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1819 1820 1803 1804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1824 1825 1808 1809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1837 1838 1821 1822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1842 1843 1826 1827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1859 1860 1843 1844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1864 1865 1848 1849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1021 1026 <span type="species:ncbi:10090">mouse</span>
###xml 1438 1442 <span type="species:ncbi:10090">mice</span>
###xml 1593 1597 <span type="species:ncbi:10090">mice</span>
###xml 1650 1655 <span type="species:ncbi:10090">mouse</span>
Cbl inactivation fails to rescue the defects of T cell development in SLP76-/-Delta20 and SLP76-/-RK mice.A, thymocytes from SLP76+/-Cbl+/- (wild type) and SLP76-/-Cbl+/- (SLP76-/-) mice were stained with antibodies specific for CD4 and CD8 (top row) or with antibodies specific for CD25 and CD44 after excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice and total numbers of thymocytes for each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4(CD4+CD8-), CD8(CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. B, thymocytes from SLP76+/-Cbl+/- (wild-type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-Delta20 (SLP76-/-Delta20) and SLP76-/-Cbl-/-Delta20 mice were stained with CD4 and CD8 (top row); or with CD25 and CD44 after excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. Results shown are representative of three independent experiments. C, thymocytes from SLP76+/-Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-RK (SLP76-/-RK), and SLP76-/- Cbl-/-RK mice were stained with CD4 and CD8 (top row) or with CD25 and CD44 excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. Results shown are representative of three or more independent experiments.
###end p 27
###begin p 28
###xml 0 115 0 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phosphorylation of Multiple Signaling Proteins in Response to TCR Signals Is Increased by Cbl Inactivation in SLP76</italic>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbl</italic>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 124 138 124 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y3F Thymocytes</italic>
###xml 264 267 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 380 383 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 403 406 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 554 557 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 571 574 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 577 580 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 717 720 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 961 964 961 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 967 970 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 992 993 992 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 986 993 986 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
Phosphorylation of Multiple Signaling Proteins in Response to TCR Signals Is Increased by Cbl Inactivation in SLP76-/-Cbl-/-Y3F Thymocytes-The findings presented above indicate that Cbl inactivation rescues the defects in early T cell development observed in SLP76-/-Y3F mice. To understand the effect of Cbl inactivation on TCR signaling, thymocytes from wild-type, Cbl-/-, SLP76-/-Y3F, and SLP76-/-Cbl-/-Y3F mice were subjected to biochemical analysis. Fig. 4A shows total protein tyrosine phosphorylation of DP thymocytes from wild-type, Cbl-/-, SLP76-/-Y3F, and SLP76-/-Cbl-/-Y3F mice in response to TCR stimulation with anti-CD3 antibody. Hyper-phosphorylation of multiple proteins was observed in stimulated Cbl-/- thymocytes relative to wild-type controls, consistent with previous reports (14, 15). Tyrosine phosphorylation in SLP76-/-Y3F thymocytes was similar to that observed in wild-type cells and was similarly enhanced by Cbl inactivation in SLP76-/-Cbl-/-Y3F thymocytes (Fig. 4A).
###end p 28
###begin p 29
###xml 233 235 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 334 337 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 344 347 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 361 364 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 368 371 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 469 472 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 481 484 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 488 491 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 549 552 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 640 641 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 634 641 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 726 733 705 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 765 767 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 814 821 793 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 914 922 890 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 968 971 944 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1007 1008 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1001 1008 977 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1044 1047 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1149 1152 1122 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1155 1158 1128 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1228 1231 1198 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1235 1238 1205 1208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1275 1278 1245 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1286 1294 1256 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 1393 1400 1363 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 1475 1482 1442 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1587 1590 1551 1554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1593 1596 1557 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
We next evaluated the status of specific signaling proteins. It has been reported that TCR-zeta chain is degraded by the Cbl-SLAP complex and that levels of total TCR-zeta protein are therefore increased in Cbl-deficient thymocytes (17). The level of expression of the TCR-zeta chain was analyzed in lysates of thymocytes from WT, Cbl-/-, SLP76-/-Y3F, and SLP76-/- Cbl-/-Y3F mice by immunoblotting with anti-TCR-zeta antibody. The level of total TCR-zeta protein in Cbl-/- or SLP76-/- Cbl-/-Y3F thymocytes was greater than that in wild-type or SLP76-/-Y3F thymocytes, consistent with the reported role of Cbl in TCR-zeta degradation (Fig. 4B). It has been demonstrated that phosphorylation of TCR-zeta in DP thymocytes occurs in vivo as a result of TCR engagement (21). When the effect of Cbl inactivation on this in vivo phosphorylation was assessed, it was found that TCR-zeta phosphorylation, in the absence of in vitro stimulation, was substantially greater in Cbl-/- thymocytes than in WT cells (Fig. 4B). TCR-zeta phosphorylation in SLP76-/- Y3F thymocytes was not substantially different from WT levels, and notably, Cbl inactivation in SLP76-/-Cbl-/-Y3F thymocytes resulted in increased TCR-zeta phosphorylation in SLP76-/- Cbl-/-Y3F comparable with that found in Cbl-/- cells. In vitro stimulation with anti-CD3 did not enhance phosphorylation substantially above the levels observed ex vivo. Thus, in addition to the effect of Cbl on total TCR-zeta protein levels, in vivo phosphorylation of TCR-zeta is markedly enhanced by Cbl inactivation, and this effect is intact in SLP76-/-Cbl-/- Y3F thymocytes.
###end p 29
###begin p 30
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 509 510 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 692 695 692 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 698 701 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 817 820 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 831 832 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 825 832 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 974 977 974 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
Phosphorylation and consequent activation of Lck have been well characterized as critical proximal events in TCR-mediated signaling. We assessed phosphorylation of Lck in the response of DP thymocytes to anti-CD3 stimulation, using antibody specific for phosphorylation of Tyr-416 of Lck, a modification that is specifically related to activation of Lck kinase activity (22, 23). SLP76-/-Y3F thymocytes had levels of Lck Tyr-416 phosphorylation similar to those of wild-type cells upon CD3 stimulation (Fig. 4B). Tyr-416 phosphorylation of Lck in response to anti-CD3 was substantially increased in Cbl-/- thymocytes relative to wild-type controls. Similarly, Tyr-416 phosphorylation of SLP76-/-Cbl-/-Y3F thymocytes in response to anti-CD3 was dramatically increased in comparison with responses of wild type or SLP76-/-Y3F (Fig. 4B). Thus, Lck phosphorylation and activation, an early step in TCR signaling and proximal to SLP76 in the signaling cascade, is intact in SLP76-/-Y3F thymocytes, as is the enhancement of this response by Cbl inactivation.
###end p 30
###begin p 31
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 396 399 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 689 696 689 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 815 816 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 809 816 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1106 1109 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1113 1116 1113 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1242 1243 1242 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1236 1243 1236 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1313 1316 1313 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1320 1323 1320 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1348 1349 1348 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1342 1349 1342 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1471 1474 1471 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1541 1544 1541 1544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1547 1550 1547 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1682 1684 1678 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 1749 1752 1741 1744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1894 1903 1886 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLP76 Y3F</italic>
###xml 1921 1922 1913 1914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1915 1922 1907 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 1982 1985 1974 1977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1988 1991 1980 1983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2122 2123 2110 2111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2116 2123 2104 2111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 2186 2189 2174 2177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1199 1203 <span type="species:ncbi:10090">mice</span>
The amino-terminal tyrosine residues of SLP76 are phosphorylated by tyrosine kinases following TCR engagement, which enables SLP76 to interact with Vav and Itk (9). The Y3F mutation eliminates the capacity of SLP76 to interact with Vav and Itk, whose activities or phosphorylation might therefore be affected in SLP76-/-Y3F thymocytes. Protein lysates from wild-type, SLP76-/-Y3F, and SLP76-/-Cbl-/-Y3F DP thymocytes were immunoprecipitated with antibodies against Vav1 and Itk, and the immunoprecipitated products were immunoblotted with antibodies against phosphotyrosine, Vav1, and Itk. In wild-type DP thymocytes, anti-CD3 stimulation resulted in phosphorylation of both Vav1 and Itk (Fig. 4C). In striking contrast, no phosphorylation of Vav1 or Itk was detected in stimulated SLP76-/-Y3F DP thymocytes (Fig. 4C). Thus, disruption of Vav- and Itk-binding sites on the SLP76 Y3F mutant molecule completely abrogates tyrosine phosphorylation of Vav and Itk in response to TCR cross-linking. Strikingly, however, Vav1 tyrosine phosphorylation in response to TCR signaling was completely restored in SLP76-/- Cbl-/-Y3F DP thymocytes, in fact to levels substantially greater than those in wild-type mice in response to TCR stimulation (Fig. 4C). In contrast, no detectable phosphorylation of Itk occurred in SLP76-/- Cbl-/-Y3F DP thymocytes (Fig. 4C), indicating that Cbl inactivation rescued the defect in Vav signaling but not the defect in Itk phosphorylation in SLP76-/-Y3F thymocytes. To further study the Vav signaling pathway in SLP76-/-Cbl-/-Y3F thymocytes, we next analyzed phosphorylation of ERKs and PLC-gamma1, proteins that are downstream in the Vav signaling pathway (24). No phosphorylation of ERKs or PLC-gamma1 was detected in SLP76-/-Y3F DP thymocytes in response to TCR stimulation, indicating that these events are normally highly dependent upon intact sites mutated in the SLP76 Y3F transgene (Fig. 4D). However, Cbl inactivation reversed this defect, and SLP76-/-Cbl-/-Y3F DP thymocytes generated substantial tyrosine phosphorylation of both PLC-gamma1 and ERKs in response to TCR stimulation (Fig. 4D). Thus, the Vav signaling rescued by Cbl inactivation in SLP76-/-Y3F thymocytes appears to be functional as reflected in these downstream events.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 296 297 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 392 393 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 395 396 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 398 399 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 624 626 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 628 630 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1052 1055 1044 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1062 1064 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1473 1476 1465 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1525 1528 1517 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1545 1548 1533 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
###xml 1480 1484 <span type="species:ncbi:10090">mice</span>
###xml 1551 1555 <span type="species:ncbi:10090">mice</span>
A widely accepted model for signal transduction during T cell development, as well as for TCR-mediated activation of mature T cells, involves critical early roles for Lck, ZAP-70, LAT, and SLP76, which in turn transduce signals to molecules, including PLC-gamma1, Vav, Itk, Gads, Grb2, and ERKs (9). Thus, deletion of ZAP-70, LAT, or SLP76 results in a profound arrest in T cell development (5, 7, 8). However, it has been demonstrated that inactivation of Cbl, a ubiquitin ligase with negative regulatory activity, can partially rescue the defects in T cell development observed in ZAP-70-, LAT-, and SLP76-deficient mice (16, 17), indicating the existence of signaling pathways, normally inhibited by Cbl, that can function in thymic T cell differentiation. To elucidate the role normally mediated by Cbl in regulating such pathways, we have utilized a series of transgenes with mutations in specific domains of SLP76. Each of these SLP76 mutants, Y3F, Delta20, and RK SLP76, partially rescues the defects in thymocyte development that occur in SLP76-/- mice (12), but mice expressing these SLP76 mutants have residual defects in thymic development. We have thus been able to study the role of Cbl by analyzing the effects of Cbl inactivation on the T cell developmental and signaling defects that result from discrete molecular lesions in the SLP76 pathway. We found that Cbl inactivation reverses the defect in thymic development in amino-terminal tyrosine mutant SLP76-/-Y3F mice but not the defects resulting from SLP76-/-Delta20 and SLP76-/-RK mice.
###end p 33
###begin p 34
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 9 84 9 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cbl inactivation rescues defects in T cell development in SLP76<sup>-/-</sup>Y3F mice.</bold>
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 247 254 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 315 316 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 340 350 340 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 456 463 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 510 511 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 514 515 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 525 526 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 557 558 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 561 562 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 597 598 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 610 611 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 615 616 615 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 632 633 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 714 726 714 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, bar graph</italic>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 806 809 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 810 811 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 823 826 823 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 831 832 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 848 851 848 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 854 857 854 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 862 863 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 875 886 875 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 924 925 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 928 929 928 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 944 945 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 948 949 948 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 981 982 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 992 995 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 996 997 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1009 1012 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1017 1018 1017 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1034 1037 1034 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1040 1043 1040 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1048 1049 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1061 1072 1061 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 1075 1087 1075 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, bar graph</italic>
###xml 1169 1170 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1180 1183 1180 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1184 1185 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1197 1200 1197 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1205 1206 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1222 1225 1222 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1228 1231 1228 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1236 1237 1236 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1249 1251 1249 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 1331 1334 1331 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 1384 1387 1384 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1390 1393 1390 1393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1406 1409 1406 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1417 1420 1417 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1423 1426 1423 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1431 1434 1431 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1436 1441 1436 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1449 1452 1449 1452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1455 1458 1455 1458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1468 1471 1468 1471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1476 1481 1476 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brown</italic>
###xml 1493 1496 1493 1496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1499 1502 1499 1502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1507 1511 1507 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 9 1556 9 1556 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><bold>Cbl inactivation rescues defects in T cell development in SLP76<sup>-/-</sup>Y3F mice.</bold><italic>A,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F mice were stained with CD4 and CD8 (<italic>top row</italic>) or with CD25 and CD44 excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of four or more experiments. <italic>B, bar graph</italic> representing the mean total cellularity of thymocytes in wild type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice (<italic>upper panel</italic>), and the mean numbers of DN, DP, CD4<sup>+</sup>CD8<sup>-</sup> (CD4), and CD4<sup>-</sup>CD8<sup>+</sup> (CD8) thymocytes in wild-type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice (<italic>lower panel</italic>). <italic>C, bar graph</italic> representing the mean numbers of DN1, DN2, DN3, and DN4 thymocytes in wild-type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice. <italic>D,</italic> expression of cell surface molecules (H57, CD5, CD69, and HSA indicated at the <italic>top</italic> of histograms) on DP, CD4, and CD8 cells of SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type, <italic>red</italic>), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>, <italic>green</italic>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F, <italic>brown</italic>), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>blue</italic>) thymocytes were assessed by flow cytometry.</p>
###xml 9 1556 9 1556 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35"><bold>Cbl inactivation rescues defects in T cell development in SLP76<sup>-/-</sup>Y3F mice.</bold><italic>A,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F mice were stained with CD4 and CD8 (<italic>top row</italic>) or with CD25 and CD44 excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of four or more experiments. <italic>B, bar graph</italic> representing the mean total cellularity of thymocytes in wild type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice (<italic>upper panel</italic>), and the mean numbers of DN, DP, CD4<sup>+</sup>CD8<sup>-</sup> (CD4), and CD4<sup>-</sup>CD8<sup>+</sup> (CD8) thymocytes in wild-type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice (<italic>lower panel</italic>). <italic>C, bar graph</italic> representing the mean numbers of DN1, DN2, DN3, and DN4 thymocytes in wild-type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice. <italic>D,</italic> expression of cell surface molecules (H57, CD5, CD69, and HSA indicated at the <italic>top</italic> of histograms) on DP, CD4, and CD8 cells of SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type, <italic>red</italic>), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>, <italic>green</italic>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F, <italic>brown</italic>), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>blue</italic>) thymocytes were assessed by flow cytometry.</p></caption>
###xml 1556 1556 1556 1556 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0100966560002"/>
###xml 0 1556 0 1556 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="35"><bold>Cbl inactivation rescues defects in T cell development in SLP76<sup>-/-</sup>Y3F mice.</bold><italic>A,</italic> thymocytes from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F mice were stained with CD4 and CD8 (<italic>top row</italic>) or with CD25 and CD44 excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes (<italic>bottom row</italic>). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. Results shown are representative of four or more experiments. <italic>B, bar graph</italic> representing the mean total cellularity of thymocytes in wild type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice (<italic>upper panel</italic>), and the mean numbers of DN, DP, CD4<sup>+</sup>CD8<sup>-</sup> (CD4), and CD4<sup>-</sup>CD8<sup>+</sup> (CD8) thymocytes in wild-type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice (<italic>lower panel</italic>). <italic>C, bar graph</italic> representing the mean numbers of DN1, DN2, DN3, and DN4 thymocytes in wild-type (<italic>n</italic> = 5), Cbl<sup>-/-</sup>(<italic>n</italic> = 5), SLP76<sup>-/-</sup>Y3F (<italic>n</italic> = 4), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>n</italic> = 5) mice. <italic>D,</italic> expression of cell surface molecules (H57, CD5, CD69, and HSA indicated at the <italic>top</italic> of histograms) on DP, CD4, and CD8 cells of SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type, <italic>red</italic>), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>, <italic>green</italic>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F, <italic>brown</italic>), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F (<italic>blue</italic>) thymocytes were assessed by flow cytometry.</p></caption><graphic xlink:href="zbc0100966560002"/></fig>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
FIGURE 2.Cbl inactivation rescues defects in T cell development in SLP76-/-Y3F mice.A, thymocytes from SLP76+/-Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-Y3F (SLP76-/-Y3F), and SLP76-/-Cbl-/-Y3F mice were stained with CD4 and CD8 (top row) or with CD25 and CD44 excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. Results shown are representative of four or more experiments. B, bar graph representing the mean total cellularity of thymocytes in wild type (n = 5), Cbl-/-(n = 5), SLP76-/-Y3F (n = 4), and SLP76-/-Cbl-/-Y3F (n = 5) mice (upper panel), and the mean numbers of DN, DP, CD4+CD8- (CD4), and CD4-CD8+ (CD8) thymocytes in wild-type (n = 5), Cbl-/-(n = 5), SLP76-/-Y3F (n = 4), and SLP76-/-Cbl-/-Y3F (n = 5) mice (lower panel). C, bar graph representing the mean numbers of DN1, DN2, DN3, and DN4 thymocytes in wild-type (n = 5), Cbl-/-(n = 5), SLP76-/-Y3F (n = 4), and SLP76-/-Cbl-/-Y3F (n = 5) mice. D, expression of cell surface molecules (H57, CD5, CD69, and HSA indicated at the top of histograms) on DP, CD4, and CD8 cells of SLP76+/-Cbl+/- (wild type, red), SLP76+/-Cbl-/- (Cbl-/-, green), SLP76-/-Cbl+/-Y3F (SLP76-/-Y3F, brown), and SLP76-/-Cbl-/-Y3F (blue) thymocytes were assessed by flow cytometry.
###end p 34
###begin p 35
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cbl inactivation rescues defects in T cell development in SLP76<sup>-/-</sup>Y3F mice.</bold>
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 238 245 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top row</italic>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 331 341 331 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom row</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 536 537 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 548 549 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 552 553 552 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 570 571 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 583 584 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 601 602 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 606 607 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 623 624 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 628 629 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 705 717 705 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, bar graph</italic>
###xml 786 787 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 797 800 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 801 802 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 822 823 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 845 848 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 853 854 853 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 866 877 866 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 915 916 915 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 919 920 919 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 935 936 935 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 939 940 939 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 972 973 972 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 983 986 983 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 987 988 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1000 1003 1000 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1008 1009 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1025 1028 1025 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1031 1034 1031 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1039 1040 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1052 1063 1052 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 1066 1078 1066 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, bar graph</italic>
###xml 1160 1161 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1171 1174 1171 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1175 1176 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1188 1191 1188 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1196 1197 1196 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1213 1216 1213 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1219 1222 1219 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1227 1228 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1240 1242 1240 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 1322 1325 1322 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 1375 1378 1375 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1381 1384 1381 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1397 1400 1397 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1408 1411 1408 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1414 1417 1414 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1422 1425 1422 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1427 1432 1427 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1440 1443 1440 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1446 1449 1446 1449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1459 1462 1459 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1467 1472 1467 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brown</italic>
###xml 1484 1487 1484 1487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1490 1493 1490 1493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1498 1502 1498 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
Cbl inactivation rescues defects in T cell development in SLP76-/-Y3F mice.A, thymocytes from SLP76+/-Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-Y3F (SLP76-/-Y3F), and SLP76-/-Cbl-/-Y3F mice were stained with CD4 and CD8 (top row) or with CD25 and CD44 excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes (bottom row). Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. Results shown are representative of four or more experiments. B, bar graph representing the mean total cellularity of thymocytes in wild type (n = 5), Cbl-/-(n = 5), SLP76-/-Y3F (n = 4), and SLP76-/-Cbl-/-Y3F (n = 5) mice (upper panel), and the mean numbers of DN, DP, CD4+CD8- (CD4), and CD4-CD8+ (CD8) thymocytes in wild-type (n = 5), Cbl-/-(n = 5), SLP76-/-Y3F (n = 4), and SLP76-/-Cbl-/-Y3F (n = 5) mice (lower panel). C, bar graph representing the mean numbers of DN1, DN2, DN3, and DN4 thymocytes in wild-type (n = 5), Cbl-/-(n = 5), SLP76-/-Y3F (n = 4), and SLP76-/-Cbl-/-Y3F (n = 5) mice. D, expression of cell surface molecules (H57, CD5, CD69, and HSA indicated at the top of histograms) on DP, CD4, and CD8 cells of SLP76+/-Cbl+/- (wild type, red), SLP76+/-Cbl-/- (Cbl-/-, green), SLP76-/-Cbl+/-Y3F (SLP76-/-Y3F, brown), and SLP76-/-Cbl-/-Y3F (blue) thymocytes were assessed by flow cytometry.
###end p 35
###begin p 36
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 115 116 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 194 197 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 217 218 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 211 218 203 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 514 516 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 518 520 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 931 932 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 925 932 917 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
The SLP76-/-Delta20 mutant lacks 20 amino acids in the proline-rich region and has lost the capacity to bind Gads (9). Cbl inactivation failed to rescue the defect in T cell development of SLP76-/-Delta20 mice (Fig. 1B), indicating that Cbl inactivation does not enable an alternative pathway capable of bypassing the requirement for Gads. Gads appears to function in binding to both SLP76 and LAT and thus in targeting SLP76-containing signaling complexes to LAT at the cell membrane and in proximity to the TCR (25, 26). The failure of Cbl inactivation to overcome the requirement for Gads binding to SLP76 suggests that there may be a relatively stringent requirement for the function of Gads in targeting SLP76-containing complexes to the cell membrane. Similarly, the signaling pathway that is defective in the RK mutant, which has lost the capacity to interact with ADAP and HPK-1, was not rescued by Cbl inactivation (Fig. 1C), indicating that no mechanisms were activated that are capable of compensating for this SLP76 mutation.
###end p 36
###begin p 37
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 857 859 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 870 871 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 872 873 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 862 873 859 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic>&#8211;<italic>D</italic></xref>
###xml 937 940 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1008 1010 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 1224 1225 1221 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1226 1227 1223 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1216 1227 1213 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic>&#8211;<italic>D</italic></xref>
###xml 1394 1397 1391 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1514 1517 1511 1514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1569 1570 1566 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1563 1570 1560 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1752 1755 1745 1748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1794 1795 1787 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1788 1795 1781 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 2158 2161 2147 2150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2190 2191 2179 2180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2184 2191 2173 2180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 2383 2386 2369 2372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2465 2468 2451 2454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2479 2480 2465 2466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2473 2480 2459 2466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1001 1006 <span type="species:ncbi:10090">mouse</span>
###xml 1328 1332 <span type="species:ncbi:10090">mice</span>
###xml 2387 2391 <span type="species:ncbi:10090">mice</span>
The amino-terminal tyrosine residues (Tyr-112, Tyr-128, and Tyr-145) of SLP76 are phosphorylated by ZAP-70 following TCR engagement, enabling SLP76 to interact with molecules, including Vav (at the Tyr-112 site), Nck (at the Tyr-128 site), and Itk (at the Tyr-145 site) (9). The interactions of SLP76 with these signaling molecules have been shown to be essential events for thymic development. The SLP76 mutant Y3F, in which three tyrosine residues (Tyr-112, Tyr-128, and Tyr-145) were substituted by phenylalanines, was introduced as a transgene into SLP76-deficient mice. Mutation of the three tyrosine residues of SLP76 results in multiple defects of T cell development, including decreased thymic size, a block in development at the DN3 stage, reduced numbers of DP and SP thymocytes, and reduced expression of TCRbeta, CD5, and CD69 on DP thymocytes (12) (Fig. 2, A-D). It is notable that the defects in T cell development in SLP76-/-Y3F mice are similar to those observed in the Vav1 knock-out mouse (24). Our data showed that the substantial defects in T cell development caused by the mutation of Tyr-112, Tyr-128, and Tyr-145 residues of SLP76 could be effectively rescued by introducing the Cbl mutation (Fig. 2, A-D). It is thus possible that rescue of defective T cell development by Cbl inactivation in Y3F mutant mice is mediated by rescue of the defect in Vav signaling in SLP76-/-Y3F thymocytes. Indeed, Cbl inactivation completely rescued the profound defect in Vav1 phosphorylation seen in SLP76-/- Y3F thymocytes in response to TCR signaling (Fig. 4C). This rescued Vav signaling by Cbl mutation might play a role in the reversal of defects involving potential downstream molecules, such as ERKs and PLC-gamma1, in response of SLP76-/-Y3F thymocytes to TCR signaling (Fig. 4D). However, it is also possible that ERK and PLC-gamma1 phosphorylation may be rescued by Vav-independent pathways that are also affected by Cbl, such as those downstream of Lck. Phosphorylation of Lck is an early event in TCR signaling and appears to be upstream of SLP76 in this cascade. Consistent with this, there was no defect in Lck phosphorylation in SLP76-/-Y3F mutant thymocytes (Fig. 4B). Inactivation of ubiquitin ligase Cbl, which results in increased levels of TCR-zeta and increased phosphorylation (and presumably increased phosphorylation-dependent activity) of Lck in Cbl-/- mice, similarly increased these responses in cells expressing the mutant SLP76-/-Y3F (Fig. 4B).
###end p 37
###begin p 38
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 374 377 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 380 383 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 963 966 956 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 969 972 962 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1092 1094 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 1304 1305 1297 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1321 1323 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1816 1819 1809 1812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1823 1826 1816 1819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1923 1925 1916 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 2091 2093 2084 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 2095 2097 2088 2090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 2128 2131 2121 2124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2135 2138 2128 2131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1115 1120 <span type="species:ncbi:10090">mouse</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
###xml 1830 1834 <span type="species:ncbi:10090">mice</span>
###xml 2142 2146 <span type="species:ncbi:10090">mice</span>
Our findings suggest that activation of Vav may be a critical pathway in the mechanism by which Cbl inactivation permits normalization of T cell development in the presence of the Y3F mutation that, in Jurkat cells, has been shown to disrupt the ability of SLP76 to interact with Vav (27). Consistent with the functional importance of normalized Vav phosphorylation in SLP76-/-Cbl-/-Y3F thymocytes is the accompanying restoration of phosphorylation of putative downstream mediators, including PLC-gamma1 and ERKs. The mechanism by which Vav is phosphorylated in the presence of Y3F mutant SLP76 is not yet established, but intact proximal events involving TCR-zeta and Lck may play a role. The interaction of Itk with SLP76 is also abrogated by the Y3F mutation in Jurkat cells. However, in contrast to the ability of Cbl inactivation to restore defective phosphorylation of Vav in response to TCR engagement, phosphorylation of Itk remained undetectable in SLP76-/-Cbl-/-Y3F thymocytes. This finding may reflect a strict requirement for the interaction of Itk with SLP76 for Itk activation (28). The Itk knock-out mouse in fact expresses less severe reductions in thymocyte numbers (60-70% of WT cellularity) and partial defects in thymocyte selection that lead to increased numbers of "innate-type" CD8+ T lymphocytes (29). Preliminary studies indicate that Cbl inactivation does not rescue these phenotypes in Itk knock-out mice (supplemental Fig. 1). It therefore appears that Cbl inactivation facilitates activation of Vav, but not Itk, in the absence of interaction of these molecules with SLP76. These results may reflect activation of Vav via multiple pathways in contrast to a strict requirement for Itk interaction with SLP76 for activation of this kinase. A potential mechanism for Vav activation in SLP76-/- Cbl-/-Y3F mice is suggested by the reported ability of Lck to directly phosphorylate and activate Vav (30). Cbl binds directly to Lck and negatively regulates Lck localization to lipid rafts, as well as mediating Lck ubiquitination and degradation independent of ZAP-70 (31, 32). Inactivation of Cbl in SLP76-/- Cbl-/-Y3F mice resulted in elevated Lck activation, which therefore might be sufficient to mediate Vav activation directly, independent of ZAP-70 or Vav interaction with SLP76.
###end p 38
###begin p 39
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 9 167 9 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TCR <italic>AND</italic> transgene rescues the defect in DN development in SLP76<sup>-/-</sup>Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76<sup>-/-</sup>Y3F.AND mice.</bold>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 243 246 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 268 271 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 309 312 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 434 435 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 439 440 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 616 617 616 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 631 632 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 635 636 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 647 648 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 663 664 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 667 668 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 680 681 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 685 686 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 698 699 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 703 704 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 758 760 758 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 829 839 825 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Histograms</italic>
###xml 9 967 9 959 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><bold>TCR <italic>AND</italic> transgene rescues the defect in DN development in SLP76<sup>-/-</sup>Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76<sup>-/-</sup>Y3F.AND mice.</bold> Thymocytes from SLP76<sup>+/-</sup> Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>+/-</sup>Cbl<sup>+/-</sup>AND, SLP76<sup>+/-</sup>Cbl<sup>-/-</sup>AND, SLP76<sup>-/-</sup> Cbl<sup>+/-</sup>Y3F.AND, and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F.AND mice were stained with CD4 and CD8 (<italic>A</italic>) or with CD25 and CD44 (<italic>B</italic>) after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes. Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. <italic>C,</italic> thymocytes were stained with anti-CD4, anti-CD8, and anti-V&#945;11. <italic>Histograms</italic> represent expression of V&#945;11 on gated CD4 SP thymocytes. Results shown are representative of three independent experiments.</p>
###xml 9 967 9 959 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><bold>TCR <italic>AND</italic> transgene rescues the defect in DN development in SLP76<sup>-/-</sup>Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76<sup>-/-</sup>Y3F.AND mice.</bold> Thymocytes from SLP76<sup>+/-</sup> Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>+/-</sup>Cbl<sup>+/-</sup>AND, SLP76<sup>+/-</sup>Cbl<sup>-/-</sup>AND, SLP76<sup>-/-</sup> Cbl<sup>+/-</sup>Y3F.AND, and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F.AND mice were stained with CD4 and CD8 (<italic>A</italic>) or with CD25 and CD44 (<italic>B</italic>) after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes. Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. <italic>C,</italic> thymocytes were stained with anti-CD4, anti-CD8, and anti-V&#945;11. <italic>Histograms</italic> represent expression of V&#945;11 on gated CD4 SP thymocytes. Results shown are representative of three independent experiments.</p></caption>
###xml 967 967 959 959 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0100966560003"/>
###xml 0 967 0 959 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="40"><bold>TCR <italic>AND</italic> transgene rescues the defect in DN development in SLP76<sup>-/-</sup>Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76<sup>-/-</sup>Y3F.AND mice.</bold> Thymocytes from SLP76<sup>+/-</sup> Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>+/-</sup>Cbl<sup>+/-</sup>AND, SLP76<sup>+/-</sup>Cbl<sup>-/-</sup>AND, SLP76<sup>-/-</sup> Cbl<sup>+/-</sup>Y3F.AND, and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F.AND mice were stained with CD4 and CD8 (<italic>A</italic>) or with CD25 and CD44 (<italic>B</italic>) after excluding CD4<sup>+</sup>/CD8<sup>+</sup>/NK1.1<sup>+</sup>/Mac-1<sup>+</sup>/Gr1<sup>+</sup>/CD3<sup>+</sup>/B220<sup>+</sup> thymocytes. Genotypes of mice used in the experiment and total thymocytes of each mouse are shown <italic>above</italic> the plots. <italic>Numbers</italic> in quadrants indicate the frequency of DN (CD4<sup>-</sup>CD8<sup>-</sup>), DP (CD4<sup>+</sup>CD8<sup>+</sup>), CD4 (CD4<sup>+</sup>CD8<sup>-</sup>), CD8 (CD4<sup>-</sup>CD8<sup>+</sup>), DN1 (CD25<sup>-</sup>CD44<sup>+</sup>), DN2 (CD25<sup>+</sup>CD44<sup>+</sup>), DN3 (CD25<sup>+</sup>CD44<sup>-</sup>), and DN4 (CD25<sup>-</sup>CD44<sup>-</sup>) thymocytes. <italic>C,</italic> thymocytes were stained with anti-CD4, anti-CD8, and anti-V&#945;11. <italic>Histograms</italic> represent expression of V&#945;11 on gated CD4 SP thymocytes. Results shown are representative of three independent experiments.</p></caption><graphic xlink:href="zbc0100966560003"/></fig>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 529 534 <span type="species:ncbi:10090">mouse</span>
FIGURE 3.TCR AND transgene rescues the defect in DN development in SLP76-/-Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76-/-Y3F.AND mice. Thymocytes from SLP76+/- Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76+/-Cbl+/-AND, SLP76+/-Cbl-/-AND, SLP76-/- Cbl+/-Y3F.AND, and SLP76-/-Cbl-/-Y3F.AND mice were stained with CD4 and CD8 (A) or with CD25 and CD44 (B) after excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes. Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. C, thymocytes were stained with anti-CD4, anti-CD8, and anti-Valpha11. Histograms represent expression of Valpha11 on gated CD4 SP thymocytes. Results shown are representative of three independent experiments.
###end p 39
###begin p 40
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 0 158 0 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TCR <italic>AND</italic> transgene rescues the defect in DN development in SLP76<sup>-/-</sup>Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76<sup>-/-</sup>Y3F.AND mice.</bold>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 253 256 253 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 300 303 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 306 309 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 406 407 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 420 421 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above</italic>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Numbers</italic>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 622 623 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 626 627 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 642 643 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 654 655 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 671 672 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 689 690 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 694 695 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 707 708 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 712 713 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 729 730 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 734 735 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 749 751 749 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 820 830 816 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Histograms</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
TCR AND transgene rescues the defect in DN development in SLP76-/-Y3F mice, and Cbl inactivation partially rescues positive selection in SLP76-/-Y3F.AND mice. Thymocytes from SLP76+/- Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76+/-Cbl+/-AND, SLP76+/-Cbl-/-AND, SLP76-/- Cbl+/-Y3F.AND, and SLP76-/-Cbl-/-Y3F.AND mice were stained with CD4 and CD8 (A) or with CD25 and CD44 (B) after excluding CD4+/CD8+/NK1.1+/Mac-1+/Gr1+/CD3+/B220+ thymocytes. Genotypes of mice used in the experiment and total thymocytes of each mouse are shown above the plots. Numbers in quadrants indicate the frequency of DN (CD4-CD8-), DP (CD4+CD8+), CD4 (CD4+CD8-), CD8 (CD4-CD8+), DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), and DN4 (CD25-CD44-) thymocytes. C, thymocytes were stained with anti-CD4, anti-CD8, and anti-Valpha11. Histograms represent expression of Valpha11 on gated CD4 SP thymocytes. Results shown are representative of three independent experiments.
###end p 40
###begin p 41
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 346 349 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 665 668 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AND</italic>
###xml 736 739 736 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 979 982 979 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1122 1125 1115 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1097 1101 <span type="species:ncbi:10090">mice</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
In addition to the effects of Cbl inactivation on early events in T cell development, we also assessed the effect of SLP76 mutation and Cbl inactivation on selection of mature SP cells, using the AND TCR transgenic model. Expression of the MHC class II-restricted AND transgene was found to overcome the defect in DN3-DN4 differentiation in SLP76-/-Y3F mice, in contrast to the failure of pre-TCR signaling to induce DN3-DN4 differentiation in these mice in the absence of a TCR transgene. These results demonstrate the difference, either quantitative or qualitative, in SLP76-dependent signaling requirements downstream of pre-TCR and transgenic TCR. Although the AND transgene allowed differentiation of DN4, DP, and SP cells in SLP76-/- Y3F mice, positive selection was notably different in these mice than in those expressing AND and wild-type SLP76. The strong skewing to differentiation of CD4 SP thymocytes that is observed in wild-type AND transgenics was absent in SLP76-/-Y3F.AND mice. In addition, the strong predominance of transgenic TCR Valpha11 and Vbeta3 observed in wild-type AND mice was altered in SLP76-/- Y3F.AND mice, where the majority of CD4 SP cells selected in these mice expressed low levels of transgenic Valpha11 and substantial levels of nontransgenic (non-Valpha11) TCR, indicating a marked skewing in positive selection in the presence of mutant SLP76. Cbl inactivation had substantial effects on both of these aspects of positive selection, resulting in skewing to differentiation of CD4 SP cells and to the predominant expression of transgenic TCR Valpha11/Vbeta3 receptors. Thus, in addition to its effects on early pre-TCR-mediated T cell development, Cbl expression substantially affects later stages of TCR-mediated positive selection in the presence of mutated SLP76.
###end p 41
###begin p 42
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 9 89 9 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cbl inactivation reverses selective signaling defects in SLP76<sup>-/-</sup>Y3F thymocytes.</bold>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 382 384 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 421 423 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 462 464 456 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 501 503 495 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 607 609 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 703 715 688 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 718 720 703 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 845 857 830 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 942 954 927 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 957 959 942 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 1089 1101 1066 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 1170 1182 1147 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1185 1191 1162 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane C</italic>
###xml 1237 1243 1214 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane S</italic>
###xml 9 1330 9 1306 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><bold>Cbl inactivation reverses selective signaling defects in SLP76<sup>-/-</sup>Y3F thymocytes.</bold> DP thymocytes were sorted from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F mice by flow cytometry and were unstimulated or stimulated with anti-CD3 Abs for 5 min at 37 &#176;C. Protein lysates were prepared from DP thymocytes. <italic>A,</italic> protein lysates were immunoblotted (<italic>IB</italic>) with anti-phosphotyrosine Ab (4G10). <italic>B,</italic> protein lysates were immunoblotted (<italic>IB</italic>) with anti-TCR-&#950;, anti-actin, anti-Lck, or anti-phospho(P)-lck antibody or were immunoprecipitated (<italic>IP</italic>) with anti-TCR-&#950; and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-TCR-&#950;,(<italic>upper panels</italic>). <italic>C,</italic> protein lysates were immunoprecipitated with anti-Vav1 and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-Vav1 (<italic>upper panels</italic>) or were immunoprecipitated with anti-ITK and immunoblotted with 4G10 and anti-ITK (<italic>lower panels</italic>). <italic>D,</italic> protein lysates were immunoprecipitated with anti-PLC&#947;1 and immunoblotted with anti-phosphotyrosine (4G10) or anti-PLC&#947;1(<italic>upper panels</italic>), or lysates were immunoblotted with anti-phospho-ERKs or anti-ERK (<italic>lower panels</italic>). <italic>Lane C</italic> indicates control cells without stimulation; <italic>lane S</italic> indicates cells were stimulated with 10 &#956;g/ml of anti-mouse CD3 antibodies for 5 min.</p>
###xml 9 1330 9 1306 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43"><bold>Cbl inactivation reverses selective signaling defects in SLP76<sup>-/-</sup>Y3F thymocytes.</bold> DP thymocytes were sorted from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F mice by flow cytometry and were unstimulated or stimulated with anti-CD3 Abs for 5 min at 37 &#176;C. Protein lysates were prepared from DP thymocytes. <italic>A,</italic> protein lysates were immunoblotted (<italic>IB</italic>) with anti-phosphotyrosine Ab (4G10). <italic>B,</italic> protein lysates were immunoblotted (<italic>IB</italic>) with anti-TCR-&#950;, anti-actin, anti-Lck, or anti-phospho(P)-lck antibody or were immunoprecipitated (<italic>IP</italic>) with anti-TCR-&#950; and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-TCR-&#950;,(<italic>upper panels</italic>). <italic>C,</italic> protein lysates were immunoprecipitated with anti-Vav1 and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-Vav1 (<italic>upper panels</italic>) or were immunoprecipitated with anti-ITK and immunoblotted with 4G10 and anti-ITK (<italic>lower panels</italic>). <italic>D,</italic> protein lysates were immunoprecipitated with anti-PLC&#947;1 and immunoblotted with anti-phosphotyrosine (4G10) or anti-PLC&#947;1(<italic>upper panels</italic>), or lysates were immunoblotted with anti-phospho-ERKs or anti-ERK (<italic>lower panels</italic>). <italic>Lane C</italic> indicates control cells without stimulation; <italic>lane S</italic> indicates cells were stimulated with 10 &#956;g/ml of anti-mouse CD3 antibodies for 5 min.</p></caption>
###xml 1330 1330 1306 1306 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0100966560004"/>
###xml 0 1330 0 1306 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="43"><bold>Cbl inactivation reverses selective signaling defects in SLP76<sup>-/-</sup>Y3F thymocytes.</bold> DP thymocytes were sorted from SLP76<sup>+/-</sup>Cbl<sup>+/-</sup> (wild type), SLP76<sup>+/-</sup>Cbl<sup>-/-</sup> (Cbl<sup>-/-</sup>), SLP76<sup>-/-</sup>Cbl<sup>+/-</sup>Y3F (SLP76<sup>-/-</sup>Y3F), and SLP76<sup>-/-</sup>Cbl<sup>-/-</sup>Y3F mice by flow cytometry and were unstimulated or stimulated with anti-CD3 Abs for 5 min at 37 &#176;C. Protein lysates were prepared from DP thymocytes. <italic>A,</italic> protein lysates were immunoblotted (<italic>IB</italic>) with anti-phosphotyrosine Ab (4G10). <italic>B,</italic> protein lysates were immunoblotted (<italic>IB</italic>) with anti-TCR-&#950;, anti-actin, anti-Lck, or anti-phospho(P)-lck antibody or were immunoprecipitated (<italic>IP</italic>) with anti-TCR-&#950; and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-TCR-&#950;,(<italic>upper panels</italic>). <italic>C,</italic> protein lysates were immunoprecipitated with anti-Vav1 and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-Vav1 (<italic>upper panels</italic>) or were immunoprecipitated with anti-ITK and immunoblotted with 4G10 and anti-ITK (<italic>lower panels</italic>). <italic>D,</italic> protein lysates were immunoprecipitated with anti-PLC&#947;1 and immunoblotted with anti-phosphotyrosine (4G10) or anti-PLC&#947;1(<italic>upper panels</italic>), or lysates were immunoblotted with anti-phospho-ERKs or anti-ERK (<italic>lower panels</italic>). <italic>Lane C</italic> indicates control cells without stimulation; <italic>lane S</italic> indicates cells were stimulated with 10 &#956;g/ml of anti-mouse CD3 antibodies for 5 min.</p></caption><graphic xlink:href="zbc0100966560004"/></fig>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 1299 1304 <span type="species:ncbi:10090">mouse</span>
FIGURE 4.Cbl inactivation reverses selective signaling defects in SLP76-/-Y3F thymocytes. DP thymocytes were sorted from SLP76+/-Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-Y3F (SLP76-/-Y3F), and SLP76-/-Cbl-/-Y3F mice by flow cytometry and were unstimulated or stimulated with anti-CD3 Abs for 5 min at 37 degreesC. Protein lysates were prepared from DP thymocytes. A, protein lysates were immunoblotted (IB) with anti-phosphotyrosine Ab (4G10). B, protein lysates were immunoblotted (IB) with anti-TCR-zeta, anti-actin, anti-Lck, or anti-phospho(P)-lck antibody or were immunoprecipitated (IP) with anti-TCR-zeta and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-TCR-zeta,(upper panels). C, protein lysates were immunoprecipitated with anti-Vav1 and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-Vav1 (upper panels) or were immunoprecipitated with anti-ITK and immunoblotted with 4G10 and anti-ITK (lower panels). D, protein lysates were immunoprecipitated with anti-PLCgamma1 and immunoblotted with anti-phosphotyrosine (4G10) or anti-PLCgamma1(upper panels), or lysates were immunoblotted with anti-phospho-ERKs or anti-ERK (lower panels). Lane C indicates control cells without stimulation; lane S indicates cells were stimulated with 10 mug/ml of anti-mouse CD3 antibodies for 5 min.
###end p 42
###begin p 43
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cbl inactivation reverses selective signaling defects in SLP76<sup>-/-</sup>Y3F thymocytes.</bold>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 159 162 159 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 170 173 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 176 179 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 373 375 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 412 414 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 453 455 447 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 492 494 486 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 598 600 589 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 694 706 679 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 709 711 694 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 836 848 821 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 933 945 918 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 948 950 933 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 1080 1092 1057 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 1161 1173 1138 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1176 1182 1153 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane C</italic>
###xml 1228 1234 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane S</italic>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 1290 1295 <span type="species:ncbi:10090">mouse</span>
Cbl inactivation reverses selective signaling defects in SLP76-/-Y3F thymocytes. DP thymocytes were sorted from SLP76+/-Cbl+/- (wild type), SLP76+/-Cbl-/- (Cbl-/-), SLP76-/-Cbl+/-Y3F (SLP76-/-Y3F), and SLP76-/-Cbl-/-Y3F mice by flow cytometry and were unstimulated or stimulated with anti-CD3 Abs for 5 min at 37 degreesC. Protein lysates were prepared from DP thymocytes. A, protein lysates were immunoblotted (IB) with anti-phosphotyrosine Ab (4G10). B, protein lysates were immunoblotted (IB) with anti-TCR-zeta, anti-actin, anti-Lck, or anti-phospho(P)-lck antibody or were immunoprecipitated (IP) with anti-TCR-zeta and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-TCR-zeta,(upper panels). C, protein lysates were immunoprecipitated with anti-Vav1 and immunoblotted with anti-phosphotyrosine Ab (4G10) and anti-Vav1 (upper panels) or were immunoprecipitated with anti-ITK and immunoblotted with 4G10 and anti-ITK (lower panels). D, protein lysates were immunoprecipitated with anti-PLCgamma1 and immunoblotted with anti-phosphotyrosine (4G10) or anti-PLCgamma1(upper panels), or lysates were immunoblotted with anti-phospho-ERKs or anti-ERK (lower panels). Lane C indicates control cells without stimulation; lane S indicates cells were stimulated with 10 mug/ml of anti-mouse CD3 antibodies for 5 min.
###end p 43
###begin p 44
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 245 248 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 251 254 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 1527 1529 1527 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 1687 1693 1687 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1695 1697 1695 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1943 1946 1943 1946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1949 1952 1949 1952 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
Because Cbl inactivation allows efficient generation of mature SP thymocytes in SLP76-/-Cbl-/-Y3F mice, we were able to examine the status of peripheral T cells in this setting. The number and frequency of peripheral CD4 and CD8 T cells in SLP76-/-Cbl-/-Y3F mice were comparable with those in wild-type mice (data not shown). However, these peripheral T cells were markedly unresponsive to TCR stimulation by anti-CD3/anti-CD28. Under conditions equivalent to those that generated robust tyrosine phosphorylation responses in SLP76-/-Cbl-/-Y3F thymocytes, neither tyrosine phosphorylation nor proliferation was induced in peripheral T cells (data not shown). Although the explanation for this discordance has not been established, it may reflect the documented differences in expression of Cbl and Cbl-b in the thymus and periphery (33). These two related ubiquitin-protein isopeptide ligases have multiple and significantly overlapping molecular targets. In the thymus, Cbl is expressed at high levels and Cbl-b at relatively low levels. Thus, inactivation of Cbl results in a high degree of overall depletion of Cbl family ubiquitin ligase activity in the thymus, with consequent abrogation of normally Cbl-mediated regulatory effects. In contrast, Cbl-b is expressed at high levels in the periphery and Cbl at low levels. Inactivation of Cbl might therefore have limited impact in the periphery, where intact Cbl-b could exert substantial regulatory effects. Deficiency of both Cbl and Cbl-b results in embryonic lethality (33), and complex strategies involving conditional inactivation of Cbl family members would therefore be required to resolve this possibility. However, Naramura et al. (14) suggested that Cbl mutation, by altering thymic TCR signaling, resulted in altered selection of thymocytes, giving rise to peripheral T cells with an attenuated ability to respond to TCR stimulation. Therefore, the abnormality observed in SLP76-/-Cbl-/-Y3F peripheral T cells might be the result of altered selection in the thymus for T cells with reduced capacity for signal transduction.
###end p 44
###begin p 45
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
The studies presented here demonstrate that Cbl normally enforces the SLP76 dependence of early T cell development by suppressing a signaling pathway that does not require SLP76 association with Vav, Nck, or Itk. This pathway has been shown to involve tyrosine phosphorylation of signaling intermediates commonly regarded as both upstream and downstream of SLP76 in pre-TCR/TCR signal transduction. The molecular complexes involved in signaling through the TCR are both complex and highly dynamic (34). Cbl, a ubiquitin-protein isopeptide ligase, interacts with numerous substrates, including multiple known mediators of T cell signaling (13). It is therefore likely that the potent effects demonstrated here for Cbl modulation of T cell development reflect the net effect of complex Cbl-mediated alterations in molecular signaling networks.
###end p 45
###begin title 46
Supplementary Material
###end title 46
###begin title 47
[Supplemental Data]
###end title 47
###begin p 48
We are grateful to Genevieve Sanchez-Howard and staff at BIOQUAL, Inc., for expert animal care and breeding. We thank Drs. Alfred Singer and Larry Samelson for their critical review of this manuscript and helpful comments on this work.
###end p 48
###begin p 49
The abbreviations used are: TCR, T cell receptor; MHC, major histocompatibility complex; DN, double negative; DP, double positive; SH2, Src homology 2; SP, single positive; ERK, extracellular signal-regulated kinase; PLC-gamma1, phospholipase C-gamma1; Ab, antibody; WT, wild type.
###end p 49

